Related Experiment Videos
Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study
J Garcia-Aymerich1, E Monsó, R M Marrades
1Respiratory and Environmental Health Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.
American Journal of Respiratory and Critical Care Medicine
|October 6, 2001
Summary
Previous hospitalizations, reduced lung function (FEV1), and under-prescribed long-term oxygen therapy (LTOT) significantly increase the risk of chronic obstructive pulmonary disease (COPD) exacerbation admissions. Current smoking, however, appears protective.
Area of Science:
- Pulmonary Medicine
- Epidemiology
- Respiratory Health
Background:
- Chronic obstructive pulmonary disease (COPD) exacerbations pose significant health and economic burdens.
- Identifying risk factors for COPD exacerbations is crucial for effective management and prevention.
- Limited information exists regarding the specific risk factors associated with COPD exacerbation admissions.
Purpose of the Study:
- To investigate the association between modifiable and non-modifiable risk factors and hospital admission for COPD exacerbation.
- To identify key predictors of COPD exacerbation requiring hospitalization.
- To inform clinical practice and public health strategies for COPD management.
Main Methods:
- A case-control study was conducted involving 86 patients admitted for COPD exacerbation (cases) and 86 clinically stable COPD patients (controls).
- Data were collected through questionnaires, spirometry, blood gas analysis, and physical examinations.
- Multivariate logistic regression analysis was employed to identify independent risk factors.
Main Results:
- Three or more COPD admissions in the prior year (OR 6.21) and lower FEV1 (OR 0.96 per unit) were significant risk factors.
- Under-prescription of long-term oxygen therapy (LTOT) showed a substantial increased risk (OR 22.64).
- Current smoking was found to be a protective factor (OR 0.30).
Conclusions:
- Previous hospital admissions, reduced lung function (FEV1), and under-prescription of LTOT are independently associated with an increased risk of COPD exacerbation hospitalization.
- These findings highlight critical areas for intervention in COPD patient care.
- Further research may explore the mechanisms behind smoking's protective effect and optimize LTOT prescription.